Analyzing Sanofi’s growth strategy: How the pharma giant is aiming to bring drugs to market faster and address chronic diseases
We mined Sanofi's investments and partnerships to discern the company’s strategic priorities.
We mined Sanofi's investments and partnerships to discern the company’s strategic priorities.
In this webinar, our expert digs into where funding is going, trends in deal activity, and which sectors are seeing the most (and least) momentum.
Tech leaders are aggressively applying cloud computing and generative AI to tackle issues in healthcare. We look at how 4 tech giants are building their positions in the industry using strategic investments, partnerships, and product launches.
We mined Nationwide’s investments and partnerships to discern the company’s strategic priorities.
We mined the CB Insights database to map 433 startups across 60 different categories, from protein design to ML security.
This report uses the CB Insights TECH Framework to rank femtech markets based on current commercial readiness and momentum.
As we approach the midpoint of the year and look towards 2025, our experts share the disruptive tech markets and trends they’re tracking across industries.
AI funding hits a 4-quarter high — fueled by massive genAI rounds — while deals continue to fall in Q1’24.
From commercializing quantum computer applications in industries like finance and healthcare to defending against quantum algorithms with new post-quantum cryptography standards, the quantum information landscape is rapidly becoming more complex. We break down the tech companies defining the quantum future.
We mined earnings calls, analyzed business relationships, and dug into investments and acquisitions to survey the AI activities of some of the world’s largest companies across industries.
We mined Google’s investments and partnerships to discern the company's strategic priorities in healthcare.
While digital health funding rebounds in Q1'24, deal count hits a multi-year low.
Discover what global leaders in pharma, financial services, industrials, and enterprise tech are doing in AI – and what it means for the future of each sector.
We mined Microsoft's acquisitions, investments, and partnerships to discern the company's strategic priorities in healthcare.
From pharma AI to space tech, we analyzed Y Combinator’s latest cohort to discern the investor’s bets outside of generative AI in key verticals.
From full-service virtual pharmacies to tech-enabled pharmacy benefit managers, we break down the tech companies driving down costs for pharmacies and improving medication access for patients.
After a tumultuous 2023, digital health funding surged in Q1’2024. What caused the rebound? And will the upward trend continue? Find out directly from the experts.
VC dealmaking slides to a 7-year low, while several blockbuster deals drive a modest rebound in funding.
We mined AstraZeneca’s partnerships, investments, and acquisitions to discern the company's strategic priorities.
The AI 100 is CB Insights' annual list of the top private AI companies in the world. From new AI architectures to precision manufacturing, this year’s winners are tackling some of the hardest challenges across industries.
From maternal and fetal health screening to virtual and hybrid fertility clinics, we break down the tech companies transforming women’s healthcare.
We break down the industries that humanoid robots will impact the most — from manufacturing and logistics to healthcare — as well as the startups leading the way.
We visualize every billion-dollar startup around the globe and profile the fastest-growing unicorn markets.
What's the state of venture? And what’s the data signaling will happen next?
We break down the humanoid robotics landscape across funding, headcount, top applications, and more.